tirzepatide double dose At a glance factsheet: for management of type 2 diabetes A Guide to Compounded Tirzepatide

If the next dose is within four days, skip the missed dose and resume your regular schedule

Our healthcare providers will explore suitable alternatives to Tirzepatide to avoid exacerbating symptoms

P.BarbourR.BasiG

Overall, at baseline, patients had a mean age of 61 years, mean BMI of 33.4, mean duration of diabetes of 13.3 years, mean HbA 1c of 8.31% (67 mmol/mol), and median insulin glargine dose of 30.0 IU/d, and 394 (82.9%) were using metformin

Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus (marketed as Mounjaro) and chronic weight management (marketed as Zepbound)

Both require dose escalation, meaning you start at a low dose and increase gradually